BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10778464)

  • 1. When and how to evaluate a patient with nephrolithiasis.
    Rivers K; Shetty S; Menon M
    Urol Clin North Am; 2000 May; 27(2):203-13. PubMed ID: 10778464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Southwestern Internal Medicine Conference: medical management of nephrolithiasis--a new, simplified approach for general practice.
    Pak CY
    Am J Med Sci; 1997 Apr; 313(4):215-9. PubMed ID: 9099151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
    Wilson DR; Pylypchuk G; Ehrig U
    Can Med Assoc J; 1979 Mar; 120(6):666-9. PubMed ID: 436048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiopathogenesis and clinical aspects of nephrolithiasis--at present].
    Ferrari L; Meschi M; Musini S; Frattini A; Savazzi GM
    Recenti Prog Med; 2003 Mar; 94(3):136-41. PubMed ID: 12677782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric therapy for kidney stones.
    Goldfarb DS
    Urolithiasis; 2019 Feb; 47(1):107-113. PubMed ID: 30478476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
    Preminger GM; Sakhaee K; Skurla C; Pak CY
    J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical evaluation and management of calcium nephrolithiasis.
    Abraham PA; Smith CL
    Med Clin North Am; 1984 Mar; 68(2):281-99. PubMed ID: 6369025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis.
    Reynolds TM
    J Clin Pathol; 2005 Feb; 58(2):134-40. PubMed ID: 15677531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of kidney stone composition in the detection of metabolic abnormalities.
    Pak CY; Poindexter JR; Adams-Huet B; Pearle MS
    Am J Med; 2003 Jul; 115(1):26-32. PubMed ID: 12867231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney stones.
    Kleeman CR; Coburn JW; Brickman AS; Lee DB; Narins RG; Ehrlich RM
    West J Med; 1980 Apr; 132(4):313-32. PubMed ID: 7385835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet and renal stone formation.
    Trinchieri A
    Minerva Med; 2013 Feb; 104(1):41-54. PubMed ID: 23392537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and prevention of kidney stones: an update.
    Frassetto L; Kohlstadt I
    Am Fam Physician; 2011 Dec; 84(11):1234-42. PubMed ID: 22150656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and treatment of pediatric idiopathic urolithiasis-revisited.
    Alon US; Zimmerman H; Alon M
    Pediatr Nephrol; 2004 May; 19(5):516-20. PubMed ID: 15015063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.